4/5/2024

Theophylline 24-Hour Extended Release Capsules and Tablets

Products Affected - Description

- Theo-24 extended release capsule, Endo Pharmaceuticals, 300 mg, bottle, 100 count, NDC 52244-0300-10
- Theophylline extended release tablet, Rhodes, 400 mg, bottle, 100 count, NDC 42858-0701-01
- Theophylline extended release tablet, Rhodes, 600 mg, bottle, 100 count, NDC 42858-0702-01

Reason for the Shortage

- Endo did not provide a reason for the shortage.
- Rhodes did not provide a reason for the shortage.
- Glenmark has theophylline 24-hour extended-release tablets available. The company is reviewing orders.

Available Products

- Theo-24 extended release capsule, Endo Pharmaceuticals, 100 mg, bottle, 100 count, NDC 52244-0100-10
- Theo-24 extended release capsule, Endo Pharmaceuticals, 200 mg, bottle, 100 count, NDC 52244-0200-10
- Theo-24 extended release capsule, Endo Pharmaceuticals, 400 mg, bottle, 100 count, NDC 52244-0400-10
- Theophylline extended release tablet, Glenmark, 400 mg, bottle, 100 count, NDC 68462-0380-01
- Theophylline extended release tablet, Glenmark, 600 mg, bottle, 100 count, NDC 68462-0356-01

Estimated Resupply Dates

- Rhodes has all presentations on back order and the company cannot estimate a release date.
- Endo has Theo-24 300 mg extended-release capsules on back order and the company cannot estimate a release date.

Updated

Updated April 5, 2024 by Leslie Jensen, PharmD, Drug Information Specialist. Created August 22, 2023 by Leslie Jensen, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.